ICD-10 Coding for Papillary Thyroid Carcinoma(C77.0, C77.0B, C77.0S)
Comprehensive guide on ICD-10 coding for papillary thyroid carcinoma, including documentation requirements and common pitfalls.
Complete code families applicable to Papillary Thyroid Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C73 | Malignant neoplasm of thyroid gland | Use when a confirmed diagnosis of thyroid cancer is present. |
|
| C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck | Use when lymph node metastasis is confirmed in thyroid cancer. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPapillary Thyroid Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Papillary Thyroid Carcinoma.
Omitting lymph node involvement
Impact
Clinical: Incomplete clinical picture, Regulatory: Non-compliance with coding standards, Financial: Potential loss of reimbursement
Mitigation
Review pathology reports, Cross-check imaging results
Using M8050/3 for thyroid primaries
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation
Use M8260/3 for papillary thyroid carcinoma.
Histologic subtype documentation
Impact
Failure to document specific histologic subtype can lead to audit issues.
Mitigation
Ensure pathology reports include detailed histologic findings.
Frequently Asked Questions
Primary Code
Malignant neoplasm of thyroid glandC73Secondary and unspecified malignant neoplasm of lymph nodes of head, face and nec